Advanced Search

Study Preview



Study Title and Description

Effects of raloxifene on fracture risk in postmenopausal women: the Raloxifene Use for the Heart Trial.



Key Questions Addressed
3 Key Question 3. What are the harms of using medications to reduce risk for primary breast cancer? Key Question 3a. Do harms of risk-reducing medications vary by timing of initiation and/or duration of use? Key Question 3b. Do harms of risk-reducing medications persist beyond discontinuation of use?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Effects of raloxifene on fracture risk in postmenopausal women: the Raloxifene Use for the Heart Trial.
Author Ensrud KE., Stock JL., Barrett-Connor E., Grady D., Mosca L., Khaw KT., Zhao Q., Agnusdei D., Cauley JA.
Country Center for Chronic Disease Outcomes Research, Veterans Affairs Medical Center, Minneapolis, Minnesota, USA. ensru001@.umn.edu
Year 2008
Numbers Pubmed ID: 17892376

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-4


Results & Comparisons

No Results found.